Amerise Biosciences Chart
Amerise Biosciences Share Key Metrics
Volume
49562.00
Market Cap
4.89 CR
LTQ@LTP
1200@0.74
ATP
0.73
Var Margin
100 %
Circuit Range
0.71-0.77
Delivery %
100 %
Value
36180.26
ASM/GSM
No
Market Lot
1
Summary
Amerise Biosciences Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
32.7
Sector P/B
1.77
Sec. Div. Yield
0.38
Amerise Biosciences Resistance and Support
Pivot 0.74
Resistance
First Resistance
0.75
Second Resistance
0.75
Third Resistance
0.76
Support
First Support
0.74
Second Support
0.73
Third Support
0.73
Amerise Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-05 | Audited Results |
| 2026-02-02 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-24 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-03 | Quarterly Results & Others |
Amerise Biosciences News
Amerise Biosciences Ltd - 531681 - Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2026 And Outcome Of The Board Meeting Held On Tuesday 5Th May 2026.
Amerise Biosciences announced its audited financial results for FY26, with revenue reaching ₹25.52 lacs and net profit at ₹1.61 lacs. The results, approved by the board on May 5, 2026, also included an unmodified auditor's opinion.
May 05 2026 17:05:00
Amerise Biosciences Ltd - 531681 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Snehjeev Ventures Private Limited, along with persons acting in concert (PACs), acquired 560,000 equity shares of Amerise Biosciences via open market. This acquisition increased their total shareholding in the company to 5.34% as of April 24, 2026, crossing the 5% threshold.
Apr 29 2026 12:04:00
About Amerise Biosciences
NSE : 0
BSE : 531681
ISIN : INE673C01020
The Company was incorporated in the State of Gujarat on27th August1984 as Sun Lame (P) Ltd. It has beenconverted into a limited company vide special resolutionpassed on 11th Oct.1993 and has acquired its present nameon 12th February 1996.During the year 1993 there was a substantial change in themanagement of the company. Majority of the directors oferstwhile company i.e. SUN LAME PRIVATE LIMITED hadresigned on 20/09/93 and Mr. Ramesh Patel presentManaging Director and Mr. Jayesh Thakkar have joined theBoard of Director. That time the company was facing labourproblem. The new management had negotiated with the labourand got rid off the problem by satisfying their dues onmutual terms as on 31/12/93 and thereafter the factory isrunning smoothly through contract labour. There was adecrement in the gross revenue of the company i.e. fromRs. 692.53 Lacs for the year ending 31/03/93 to Rs. 348.15Lacs for the year ending 31/03/94. Upto the year ending31/03/93 the accumulated losses were 70.58 lacs which havebeen converted into profits of Rs. 0.16 lacs upto the yearending 31/03/95.
Amerise Biosciences Management
| Name | Position |
|---|---|
| Kelash Bunkar | Non Executive Independent Director |
| Manisha Patel | Non Executive Independent Director |
Amerise Biosciences Similar Stocks
Inditrade Capital Ltd.
2.88
0.00 (0.00%)
Agarwal Fortune India Ltd.
19.62
0.00 (0.00%)
Williamson Financial Services Ltd.
5.40
0.00 (0.00%)
Kinetic Trust Ltd.
36.50
0.12 (0.33%)
M Lakhamsi Industries Ltd.
0.00
0.00 (0.00%)
AF Enterprises Ltd.
1.82
0.00 (0.00%)
Darjeeling Industriies Ltd.
41.10
-2.08 (4.82%)
Explicit Finance Ltd.
10.00
0.00 (0.00%)
Clio Infotech Ltd.
9.80
0.46 (4.93%)
Ganesh Holdings Ltd.
79.45
0.00 (0.00%)
Amerise Biosciences FAQs
